Detalhe da pesquisa
1.
End points in clinical trials in diffuse large B-cell lymphoma: time for more dialogue?
Future Oncol
; : 1-15, 2024 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38889345
2.
Design of a clinical trial using generalized pairwise comparisons to test a less intensive treatment regimen.
Clin Trials
; 21(2): 180-188, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37877379
3.
A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration.
Ophthalmology
; 130(6): 588-597, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36754174
4.
Minimization in randomized clinical trials.
Stat Med
; 42(28): 5285-5311, 2023 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37867447
5.
Individualized Net Benefit estimation and meta-analysis using generalized pairwise comparisons in N-of-1 trials.
Stat Med
; 2023 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36597195
6.
On the use of extreme value tail modeling for generalized pairwise comparisons with censored outcomes.
Pharm Stat
; 22(2): 284-299, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36321470
7.
Generalized pairwise comparisons for censored data: An overview.
Biom J
; 65(2): e2100354, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36127290
8.
Surrogacy Beyond Prognosis: The Importance of "Trial-Level" Surrogacy.
Oncologist
; 27(4): 266-271, 2022 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35380717
9.
Acoramidis in Transthyretin Amyloid Cardiomyopathy.
N Engl J Med
; 390(14): 1345-1346, 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38598811
10.
The case against censoring of progression-free survival in cancer clinical trials - A pandemic shutdown as an illustration.
BMC Med Res Methodol
; 22(1): 260, 2022 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36199019
11.
Using an interim analysis based exclusively on an early outcome in a randomized clinical trial with a long-term clinical endpoint.
Pharm Stat
; 21(1): 209-219, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34505395
12.
The International Collaboration for Research methods Development in Oncology (CReDO) workshops: shaping the future of global oncology research.
Lancet Oncol
; 22(8): e369-e376, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34216541
13.
Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS).
Cancer
; 127(23): 4421-4431, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34424530
14.
Net benefit in the presence of correlated prioritized outcomes using generalized pairwise comparisons: A simulation study.
Stat Med
; 40(3): 553-565, 2021 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33140505
15.
Correcting the bias of the net benefit estimator due to right-censored observations.
Biom J
; 63(4): 893-906, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33615533
16.
A new measure of treatment effect in clinical trials involving competing risks based on generalized pairwise comparisons.
Biom J
; 63(2): 272-288, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32939818
17.
Outcome measures in multimodal rectal cancer trials.
Lancet Oncol
; 21(5): e252-e264, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32359501
18.
Statistical aspects in adjuvant and neoadjuvant trials for gastrointestinal cancer in 2020: focus on time-to-event endpoints.
Curr Opin Oncol
; 32(4): 384-390, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32541329
19.
Central statistical monitoring of investigator-led clinical trials in oncology.
Int J Clin Oncol
; 25(7): 1207-1214, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32577951
20.
Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis.
Lancet Oncol
; 20(3): 361-370, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30709633